Cargando…
Botulinum toxin type A interrupts autophagic flux of submandibular gland
Botulinum toxin type A (BTXA) is a neurotoxic protein produced by Clostridium botulinum. Our previous studies demonstrated that BTXA inhibits the secretory function of submandibular gland (SMG) and changes its structure. Several studies reported that SMG damage and repair often occur with autophagy...
Autores principales: | Xie, Shang, Xu, Hui, Shan, Xiao-Feng, Cai, Zhi-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646452/ https://www.ncbi.nlm.nih.gov/pubmed/31273059 http://dx.doi.org/10.1042/BSR20190035 |
Ejemplares similares
-
An Experimental Study on Botulinum Toxin Type A for the Treatment of Excessive Secretion after Submandibular Gland Transplantation in Rabbits
por: Xie, Shang, et al.
Publicado: (2016) -
Botulinum toxin A inhibits salivary secretion of rabbit submandibular gland
por: Shan, Xiao-Feng, et al.
Publicado: (2013) -
Submandibular Gland Reduction Using Botulinum Toxin Type A for a Smooth Jawline
por: Jung, Gyu Sik, et al.
Publicado: (2019) -
Safety of High-Dose Botulinum Toxin Injections for Parotid and Submandibular Gland Radioprotection
por: Mueller, Joerg, et al.
Publicado: (2022) -
Efficacy and safety of botulinum toxin type A for treatment of Frey’s syndrome: evidence from 22 published articles
por: Xie, Shang, et al.
Publicado: (2015)